全文获取类型
收费全文 | 1184篇 |
免费 | 60篇 |
国内免费 | 10篇 |
专业分类
耳鼻咽喉 | 10篇 |
儿科学 | 36篇 |
妇产科学 | 29篇 |
基础医学 | 122篇 |
口腔科学 | 26篇 |
临床医学 | 152篇 |
内科学 | 249篇 |
皮肤病学 | 17篇 |
神经病学 | 97篇 |
特种医学 | 75篇 |
外科学 | 176篇 |
综合类 | 26篇 |
预防医学 | 114篇 |
眼科学 | 10篇 |
药学 | 76篇 |
中国医学 | 6篇 |
肿瘤学 | 33篇 |
出版年
2022年 | 7篇 |
2021年 | 10篇 |
2019年 | 12篇 |
2018年 | 15篇 |
2017年 | 10篇 |
2016年 | 15篇 |
2015年 | 18篇 |
2014年 | 27篇 |
2013年 | 48篇 |
2012年 | 40篇 |
2011年 | 53篇 |
2010年 | 53篇 |
2009年 | 46篇 |
2008年 | 47篇 |
2007年 | 48篇 |
2006年 | 47篇 |
2005年 | 54篇 |
2004年 | 50篇 |
2003年 | 42篇 |
2002年 | 27篇 |
2001年 | 39篇 |
2000年 | 36篇 |
1999年 | 36篇 |
1998年 | 19篇 |
1997年 | 28篇 |
1996年 | 19篇 |
1995年 | 18篇 |
1994年 | 32篇 |
1993年 | 21篇 |
1992年 | 23篇 |
1991年 | 31篇 |
1990年 | 31篇 |
1989年 | 15篇 |
1988年 | 20篇 |
1987年 | 26篇 |
1986年 | 17篇 |
1985年 | 10篇 |
1984年 | 7篇 |
1983年 | 7篇 |
1982年 | 10篇 |
1980年 | 7篇 |
1978年 | 7篇 |
1977年 | 5篇 |
1974年 | 6篇 |
1967年 | 5篇 |
1958年 | 14篇 |
1957年 | 13篇 |
1956年 | 10篇 |
1955年 | 12篇 |
1954年 | 15篇 |
排序方式: 共有1254条查询结果,搜索用时 15 毫秒
61.
Kyrolainen H Kivela R Koskinen S McBride J Andersen JL Takala T Sipila S Komi PV 《Medicine and science in sports and exercise》2003,35(1):45-49
PURPOSE: The present study was designed to investigate possible differences in running economy (RE) among elite middle-distance runners by examining muscle structure and maximal isometric force (MVC). METHODS: Ten young male runners ran at six different running speeds. During the running bouts, respiratory gases, and blood lactate were measured. Muscle biopsies were obtained from the vastus lateralis muscle for analyzing fiber type distribution, muscle fiber area, myosin heavy chain (MHC) composition, activities of a number of metabolic enzymes (citrate synthase, lactate dehydrogenase, phosphofruktokinase, and 3-hydroxyacyl-CoA-dehydrogenase), and titin isoforms. RESULTS: Energy expenditure (EE) increased linearly up to the speed of 6.0 m.s. The relative distribution of the MHC isoforms was MHC I: 67.0%, MHC IIA: 31.5%, and MHC IIX: 1.5%. The present results demonstrated that higher the area of Type II fibers, higher the MVC (r = 0.59, P< 0.05). The amount of MHC II correlated inversely with EE when running close to the competition speed (r = -0.61, P< 0.05). Enzyme activities did not correlate significantly with either RE or EE. Titin analysis revealed that a faster-mobility titin band was observed in all subjects, whereas a lower-mobility titin band was observed only in the most economical runner. CONCLUSION: Differences in RE among homogeneous group of middle-distance runners were observed at various running speeds. This may partly be explained by differences in muscle fiber distribution, MHC composition, and titin isoforms. 相似文献
62.
The present investigation was undertaken in order to study whether microvascular effects of the calcium antagonist nimodipine induces changes that can explain an increased detoxification of the highly toxic cholinesterase inhibitor soman. Anaesthetised, tracheotomised and artificially ventilated rats were treated intra-peritoneally (ip) with nimodipine, 10 mg kg(-1) or vehicle followed one hour later by the exposure to 45 microg kg(-1) soman (iv). Nimodipine per se induced a vasodilation in the intestine, myocardium and other muscles. In the abdominal skin soman elicited a significant vasoconstriction that was turned into an increased blood flow after nimodipine pre-treatment. A slight vasoconstriction in diaphragm of soman intoxicated rats was turned into a significant vasodilation by nimodipine pre-treatment. In the intestinal parts no effect of soman was detected. However, in nimodipine pretreated animals soman induced a significant vasoconstriction. The capacity of soman detoxifying processes, i.e. enzymatic hydrolysis and covalent binding to different esterases, is unequally distributed throughout the body. Together with the knowledge of the detoxifying processes of cholinesterase inhibition the results support our theory, that nimodipine alters the peripheral blood flow in a beneficial way resulting in improved detoxification ability. 相似文献
63.
64.
Appelberg BG Syvälahti EK Koskinen TE Mehtonen OP Muhonen TT Naukkarinen HH 《The Journal of clinical psychiatry》2001,62(6):448-452
BACKGROUND: Although case reports and open studies have reported augmentation with buspirone to be beneficial in the treatment of depression refractory to treatment with a selective serotonin reuptake inhibitor (SSRI), a recently published randomized, placebo-controlled, double-blind study failed to show superiority of buspirone over placebo in this respect. METHOD: One hundred two outpatients who fulfilled DSM-IV criteria for a major depressive episode and who had failed to respond to a minimum of 6 weeks of treatment with either fluoxetine or citalopram were included in this double-blind, randomized, placebo-controlled study. After a single-blind placebo wash-in period of 2 weeks while continuing their SSRI, the patients were randomly assigned to adjunctive treatment with either buspirone, 10 to 30 mg b.i.d., or placebo for 6 weeks. Patients were assessed using the Montgomery-Asberg Depression Rating Scale (MADRS), the Clinical Global Impressions scale (CGI), and visual analogue scales. RESULTS: After the first week of double-blind treatment, there was a significantly greater reduction in MADRS score (p = .034) in the buspirone group as compared with placebo. At endpoint, there was no significant difference between treatment groups as a whole, although patients with initially high MADRS scores (> 30) showed a significantly greater reduction in MADRS score (p = .026) in the buspirone group as compared with placebo. CONCLUSION: Patients with severe depressive symptoms may benefit from augmentation with buspirone. It cannot be excluded that augmentation with buspirone may speed up the antidepressive response of patients refractory to treatment with fluoxetine or citalopram. 相似文献
65.
66.
67.
68.
69.
Variables affecting quantitative biliary scintigraphy in asymptomatic cholecystectomized volunteers 总被引:3,自引:0,他引:3
Sand JA Turjanmaa VM Koskinen MO Makinen AM Nordback IH 《Hepato-gastroenterology》1999,46(25):130-135
BACKGROUND/AIMS: Quantitative cholescintigraphy has been used to evaluate biliary emptying and, by some, as a screening test for sphincter of Oddi dyskinesia in cholecystectomized patients. Our aim was to identify variables that might effect the interpretation of the scintigraphy in asymptomatic cholecystectomized volunteers. METHODOLOGY: Quantitative cholescintigraphy was performed in 37 volunteer. There were 11 males and 26 females with a median age of 49 years (range: 32-82). The time interval from cholecystectomy ranged from 1 month to 30 years (median: 5 years). Eight subjects had also undergone choledocholithotomy during the cholecystectomy operation. RESULTS: From the time of the injection of the radioisotope to the maximum activity in the liver, the percentage of clearance and the hepatic hilum-duodenal transit time were measured to be 45 and 60 min, respectively. The maximum activity obtained in the liver was 17 +/- 10 min (mean +/- SD), and the percentage of clearance at 45 min was 52 +/- 22% and at 60 min 67 +/- 20%. Hilum-duodenal transit time was 12 +/- 11 min. The gender of the volunteer and previous choledocholithotomy did not correlate with the parameters studied. The age of the volunteer and the follow-up time had a positive correlation to the time of maximum activity and negative correlation to percentage of clearance. The follow-up time also had a positive correlation to hilum-duodenal transit time. In the multivariate analysis, the time interval since cholecystectomy was the only independent variable affecting study parameters. CONCLUSIONS: The length of the time interval since cholecystectomy but not the gender, age, or previous choledocholithotomy should be taken into consideration when the results of quantitative cholescintigraphy are interpreted. 相似文献
70.
Interferon-alpha (IFN-alpha) is a pleiotropic cytokine that has antiviral, antiproliferative, and immunoregulatory functions. There is increasing evidence that IFN-alpha has an important role in T-cell biology. We have analyzed the expression of IL-2Ralpha, c-myc, and pim-1 genes in anti-CD3-activated human T lymphocytes. The induction of these genes is associated with interleukin-2 (IL-2)-induced T-cell proliferation. Treatment of T lymphocytes with IFN-alpha, IL-2, IL-12, and IL-15 upregulated IL-2Ralpha, c-myc, and pim-1 gene expression. IFN-alpha also sensitized T cells to IL-2-induced proliferation, further suggesting that IFN-alpha may be involved in the regulation of T-cell mitogenesis. When we analyzed the nature of STAT proteins capable of binding to IL-2Ralpha, pim-1, and IRF-1 GAS elements after cytokine stimulation, we observed IFN-alpha-induced binding of STAT1, STAT3, and STAT4, but not STAT5 to all of these elements. Yet, IFN-alpha was able to activate binding of STAT5 to the high-affinity IFP53 GAS site. IFN-alpha enhanced tyrosine phosphorylation of STAT1, STAT3, STAT4, STAT5a, and STAT5b. IL-12 induced STAT4 and IL-2 and IL-15 induced STAT5 binding to the GAS elements. Taken together, our results suggest that IFN-alpha, IL-2, IL-12, and IL-15 have overlapping activities on human T cells. These findings thus emphasize the importance of IFN-alpha as a T-cell regulatory cytokine. 相似文献